Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript
Hi. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome John Maraganore, the CEO of Alnylam. This is a fireside chat format. Thanks for joining us today, John.
Pleasure to be here, Maury. Thank you.
Questions & Answers
So maybe to start off, if you can provide a 1-minute overview of Alnylam.
Yes. Thanks. Alnylam is the pioneering company in RNAi therapeutics. We brought 4 products to the market, 3 that we directly commercialize globally, 1 that we're partnered with Novartis. And all of these medicines, at least in our view, have really been transformative for patients. So we're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
